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Abstract
Common neurodegenerative proteinopathies, such as Alzheimer’s disease (AD) and Parkinson’s disease (PD),
are characterized by the misfolding and aggregation of toxic protein species, including the amyloid beta (Aß)
peptide, microtubule-associated protein Tau (Tau), and alpha-synuclein (αSyn) protein. These factors also show toxicity in
Drosophila; however, potential limitations of prior studies include poor discrimination between effects on the adult versus
developing nervous system and neuronal versus glial cell types. In addition, variable expression paradigms and outcomes
hinder systematic comparison of toxicity profiles. Using standardized conditions and medium-throughput assays, we
express human Tau, Aß or αSyn selectively in neurons of the adult Drosophila retina and monitor age-dependent changes
in both structure and function, based on tissue histology and recordings of the electroretinogram (ERG), respectively.
We find that each protein causes a unique profile of neurodegenerative pathology, demonstrating distinct and separable
impacts on neuronal death and dysfunction. Strikingly, expression of Tau leads to progressive loss of ERG responses
whereas retinal architecture and neuronal numbers are largely preserved. By contrast, Aß induces modest, age-dependent
neuronal loss without degrading the retinal ERG. αSyn expression, using a codon-optimized transgene, is characterized
by marked retinal vacuolar change, progressive photoreceptor cell death, and delayed-onset but modest ERG changes.
Lastly, to address potential mechanisms, we perform transmission electron microscopy (TEM) to reveal potential
degenerative changes at the ultrastructural level. Surprisingly, Tau and αSyn each cause prominent but distinct
synaptotoxic profiles, including disorganization or enlargement of photoreceptor terminals, respectively. Our findings
highlight variable and dynamic properties of neurodegeneration triggered by these disease-relevant proteins in vivo, and
suggest that Drosophila may be useful for revealing determinants of neuronal dysfunction that precede cell loss, including
synaptic changes, in the adult nervous system.
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Introduction
Alzheimer’s disease (AD) [46] and Parkinson’s disease (PD)
[32] are common and incurable neurodegenerative disorders
responsible for substantial cognitive and/or motor disability
in the aging population. Both disorders are characterized at
autopsy by widespread neuronal loss within the central
nervous system in association with aggregated and mis-
folded toxic protein species. AD is neuropathologically
defined by the presence of amyloid plaques and neuro-
fibrillary tangles, predominantly consisting of extracel-
lular Aß peptide deposits and intracellular filamentous
aggregates of the microtubule associated protein Tau
(MAPT/Tau), respectively. Similarly, intracellular inclu-
sions of alpha-synuclein protein (SNCA/αSyn) com-
prise the Lewy bodies that pathologically define PD.
Importantly, since rare mutations in the amyloid
precursor protein, MAPT, and SNCA genes all cause
Mendelian, young-onset forms of dementia and/or
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parkinsonism, the misfolded and aggregated proteins
that form pathological inclusions in AD and PD are
causatively linked to disease pathogenesis. Further sup-
port comes from numerous transgenic animal models
[16, 23] in which expression of Aß, Tau, or αSyn have
been demonstrated to recapitulate neurotoxicity and
often other clinicopathologic features relevant to hu-
man disease.
AD and PD are also similarly characterized by a pro-
longed, insidious onset in which absent or subtle
symptoms precede more severe cognitive and motor
disability and clinical recognition. While part of the
age-dependent progression certainly relates to the cu-
mulative toll of neuronal loss and failure of compensa-
tory mechanisms, it is increasingly apparent that a
period of cellular dysfunction precedes death [27]. For
example, fibrillar Aß pathology has been associated
with altered measures of brain metabolism [3, 31] and
connectivity [55] and these changes might potentially be
explained in part by synaptic loss and dysfunction seen in
experimental models. Similarly, clinicopathologic studies
of PD suggest dopaminergic terminal dysfunction pre-
cedes nigral cell death [29], potentially contributing to
early clinical manifestations of disease. Indeed, a current
priority is to develop strategies to identify affected individ-
uals earlier allowing potential therapeutic intervention be-
fore irreversible cell death [54].
Robust experimental models of neuronal dysfunction
in AD and PD are therefore urgently needed, including
systems amenable to rapid genetic manipulation and
medium to high-throughput screening. The fruit fly,
Drosophila melanogaster, has been a valuable tool for
studying neurodegenerative disorders, and numerous
transgenic models have been reported based on expres-
sion of human Aß, Tau, and αSyn. In particular, given its
accessibility and dispensability, the fly eye has proven a
versatile experimental system, and Aß, Tau, and αSyn
have all been associated with retinal toxicity [9, 20, 28,
33, 52]. However, prior studies of these Drosophila AD/
PD transgenic models have used different expression
conditions and assays, hindering systematic comparisons
of toxicity profiles. Further, many studies have utilized
expression drivers that do not allow differentiation of
toxicity in (1) the adult versus developing nervous
system and/or (2) neuronal versus non-neuronal sup-
porting cells (glia). Here, we use standardized conditions
and assays to systematically examine neurodegenerative
changes induced by Aß, Tau, and αSyn, including the
evaluation of both structural and functional changes fol-
lowing selective expression in the neuronal cells of the
adult retina. These studies demonstrate that each pro-
tein recapitulates a unique profile of neurodegenerative
pathology, demonstrating distinct and apparently separ-
able impacts on neuronal death and dysfunction.
Materials and Methods
Drosophila Stocks and husbandry
The following previously reported Drosophila stocks were
obtained for our experiments: Rh1-GAL4 (II)[63], UAS-
TauWT11 [62], and UAS-alpha-synuclein [18]. The UAS-
TauWT11 transgene expresses the full-length, 383-amino
acid isoform of human Tau, lacking amino terminal in-
serts (exons 2 and 3) and containing 4 microtubule bind-
ing repeats (0N4R). The UAS-Aß and codon-optimized
UAS-αSyn strains are newly reported in this study but are
both available in the Bloomington Drosophila Stock Cen-
ter: P{UAS-APP.Abeta42.B}m26a and P{UAS-SNCA.J}7.
The UAS-Aß line consists of the open reading frame
encoding the 42 amino acid Aß fragment of human APP
fused with the fly argos secretion signal peptide under the
control of UAS in the P{UAST} vector. The resulting
amino acid sequence is (argos sequence italicized):
MPTTLMLLPCMLLLLLTAAAVAVGGDAEFRHDSGYEV
HHQKLVFFAEDVGSNKGAIIGLMVGGVVIA
Expression of the Aß peptide was confirmed and quanti-
fied by ELISA (Additional file 1: Figure S1). To extract
total Aβ42, 7 heads were homogenized in 50 μL GnHCl
extraction buffer (5 M guanidinium HCl, protease inhibi-
tor cocktail (GenDEPOT) and 50 mM Tris HCl, pH= 8.0).
Following centrifugation (14,000 g for 15 min @ 4 °C),
supernatant was diluted 1:50, 1:100 and 1:200 in standard
dilution buffer, before performing ELISA measurements
(Invitrogen, KHB3441) following the manufacturer’s proto-
col. The codon-optimized UAS-alpha-synuclein line was
developed from a synthetic human alpha-synuclein cDNA
engineered by DNA 2.0 (Menlo Park, CA) using codons
optimized for insect expression. The resulting cDNA, en-
coding full-length, wild-type human alpha-synuclein pro-
tein, was subcloned into the pExpress-UAS expression
vector [43]. Expression of αSyn was confirmed by immu-
noblot (clone 42, BD Transduction Laboratories, 1:1000)
(Additional file 1: Figure S1). Immunoblot was also per-
formed for Tau (Dako, 1:5000). Expression of Tau and
αSyn were quantified relative to recombinant, purified
protein standards of known concentration (Tau: Abcam,
Cambridge, UK; αSyn: EMD Millipore, Temecula, CA). All
crosses were established at 18 °C, and adult progeny were
transferred to 25 °C between 0–24 hours post-eclosion for
aging and subsequent analyses. Flies were maintained in
continuous, ambient laboratory light conditions. Female
flies were used for all analyses.
Retinal histology
Adult flies were fixed in 8 % glutaraldehyde (EM grade)
and embedded in paraffin. Frontal (5 μm) and tangential
(3 μm) retinal sections were prepared on the microtome
(Leica) and stained with hematoxylin and eosin. At least 4
animals were examined for each genotype and preparation
(frontal and tangential sections). Frontal retinal sections
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(Fig. 2) were photographed at the level of the giant com-
missure interneurons, posterior to the fan-shaped body.
As in prior work [40], we quantified the number of om-
matidia in which 7 photoreceptor rhabdomeres remained
intact within each field of view (100x) centered within
well-oriented, retinal sections from each animal (Fig. 3).
Electrophysiology
ERG recordings were performed as previously described
[64]. In brief, adult flies were anesthetized and glued to a
glass slide. A reference electrode was inserted in the thorax
and the recording electrode was placed on the corneal sur-
face of the eye. Flies were maintained in the darkness for at
least 5 minute prior to a train of 10, 1-second flashes of
white light pulses (LED source with daylight filter), during
which retinal responses were recorded and analyzed using
WinWCP (University of Strathclyde, Glasgow, Scotland)
and AxoGraph (Berkeley, CA), respectively. At least 6 flies
were examined for each genotype and timepoint.
TEM
Both retinae and laminae in adult flies were processed for
TEM imaging as described [58]. Samples were processed
using a Ted Pella Bio Wave microwave oven with vacuum
attachment. Adult fly heads were dissected at 25 °C in 4 %
paraformaldehyde, 2 % glutaraldehyde, and 0.1 M sodium
cacodylate (pH 7.2). Samples were subsequently fixed at
4 °C for 48 hours. 1 % osmium tetroxide was used for sec-
ondary fixation and subsequently dehydrated in ethanol
and propylene oxide, and then embedded in Embed-812
resin (Electron Microscopy Science, Hatfield, PA). 50 nm
ultra-thin sections were obtained with a Leica UC7 micro-
tome and collected on Formvar-coated copper grids (Elec-
tron Microscopy Science, Hatfield, PA). Specimens were
stained with 1 % uranyl acetate and 2.5 % lead citrate and
imaged using a JEOL JEM 1010 transmission electron
microscope with an AMT XR-16 mid-mount 16 mega-
pixel CCD camera. For quantification of ultrastructural
features, electron micrographs were examined from 3 dif-
ferent animals per genotype.
Statistical analysis
For primary analyses of ERG (Fig. 1) and rhabdomere loss
(Fig. 3), two-way ANOVA was implemented to detect po-
tential differences between group mean outcomes by geno-
type and age. The overall model F-test is reported in the
relevant figure legends. Subsequently, subsetted student’s
t-tests (2-tailed) were performed for post-hoc comparisons
of control animals with each experimental genotype (Tau,
Aß, or αSyn), considering each timepoint independently;
Bonferroni adjustment was performed in order to correct
p-values for multiple comparisons [padjusted = punadjusted * 3,
for n = 3 genotypes). For secondary analyses of TEM pa-
rameters, statistical comparisons were implemented using
a two-tailed student’s t-test. Error bars in all analyses rep-
resent the standard error of the mean (SEM, 95 % confi-
dence interval).
Results
The transgenic models utilized for this comparative study
take advantage of the GAL4-UAS system [7], in which
cDNAs encoding human Tau (0N4R isoform), the Aß42
peptide, or full-length αSyn protein are under control of
the heterologous yeast Upstream Activating Sequence
(UAS) promoter element and responsive to driver lines
expressing the GAL4 transcription factor. We selected the
Rhodopsin1-GAL4 (Rh1) line that is expressed following
photoreceptor maturation and is thus only active follow-
ing completion of eye development beginning in late
pupal stages [47]. This permits the study of potential toxic
properties within neurons, excluding the potential contri-
bution of glial or supporting cells. In addition, use of the
Rh1 driver further excludes the potential delayed contri-
bution of developmental toxic mechanisms. Since the
GAL4-UAS system is temperature sensitive, all crosses
were additionally carried out at 18 °C, and shifted to 25 °C
following eclosion, further restricting transgene expression
to adulthood [39]. In order to facilitate comparisons of
resulting toxicities, we determined the absolute expression
level of Tau, Aß, and αSyn under the standardized experi-
mental conditions (Additional file 1: Figure S1). For Tau
and αSyn, Western blots prepared from 10-day old adult
fly heads and quantified relative to recombinant purified
protein standards at known concentration (See Materials
and Methods and Additional file 1: Figure S1). Aß was
quantified using an established ELISA. Based on this, we
estimate the relative molar concentration for expression
of Aß, Tau, and αSyn driven by Rh1-Gal4 at 1:36:232, re-
spectively. Animals were examined using complementary
structural and functional assays to assess the toxic effects
of each human protein in the fly retina. For structural
studies, we used hematoxylin and eosin stained histologic
sections to reveal photoreceptor integrity in the retina and
lamina. Retinal function was probed using the ERG, per-
mitting assessment of light-induced photoreceptor field
potentials and efficacy of synaptic transmission [60].
Tau
In prior work, expression of human Tau transgenes in the
fly nervous system has been associated with substantial
neurotoxicity, including in the fly eye, and these models
have proven useful for both mechanistic investigation and
genetic screening [19]. The most widely deployed assay
has been the “rough eye”, typically induced using the
GMR-GAL4 driver, in which disrupted retinal develop-
ment leads to a reduced eye size and a roughened surface.
While the Tau-induced rough eye has shown great utility
for genetic studies, especially modifier screens [1, 5, 52],
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potential limitations include the developmental compo-
nent, as well as an inability to examine age-dependent
changes, since the phenotype is established during devel-
opment. Previously published and well-characterized
UAS:Tau transgenic lines [62], expressing the 383 amino
acid, wild-type human 0N4R isoform, were crossed to the
Rh1 driver. Compared to the rough eye caused by other
eye drivers, the external eye appearance of Rh1 > Tau is
indistinguishable from control animals (Additional file 2:
Figure S2).
ERGs permit assessment of light induced field potentials
serving as a sensitive indicator of photoreceptor function,
retinal integrity/degeneration, and efficacy of synaptic
transmission [60]. On eclosion (1 day old), Rh1 > Tau flies
demonstrated normal ERGs, consisting of an approximately
10 mV, light induced depolarization (Fig. 1). However, with
aging, Tau expression was associated with a significant loss
of the light-evoked ERG response, consistent with progres-
sive photoreceptor dysfunction. By contrast with preserved
ERGs in aged Rh1-GAL4 flies, Rh1 > Tau showed a 51 %
reduction (p < 0.001) in phototransduction (depolarization
amplitude) by 10 days progressing to an 81 % loss (p <
0.001) by 30 days (Fig. 1). We also quantified changes in
the ERG ON/OFF transient responses, which denote syn-
aptic neurotransmission. Under the conditions used for
ERG recordings, it was difficult to detect robust reductions
in the ON transient potential due to its small magnitude
(~0.5 mV in Rh1-GAL4 / + controls). However, at all three
time points examined, we observed significant reductions
in the ERG OFF transient potential compared to controls
(Fig. 1d).
In order to assess the integrity of the Drosophila visual
system, and to examine for photoreceptor cell loss, we pre-
pared semi-thin sections of fixed and paraffin-embedded
Fig. 1 Age-dependent changes in retinal function monitored using electroretinograms. a Representative ERG traces are shown for each genotype
examined at 1, 10, and 30 days. The overall depolarization amplitude (Δ) reflects the output of the phototransduction cascade. Synaptic neurotransmission
generates the ON and OFF transient potentials (arrowheads). b Quantification of ERG depolarization amplitude by genotype and age (2-way ANOVA
model F-test, p < 0.001). Rh1 > Tau causes a rapid and progressive loss of ERG depolarization whereas Rh1 > αSyn causes a relatively modest and late
decline. c & d Quantitation of the synaptic ON and OFF transient potentials reveals efficacy of photoreceptor neurotransmission (2-way ANOVA p < 0.001
for each model). The measurement of the ON transient c is less reliable due to its small magnitude in controls (panel A). Rh1 > Tau and Rh1 > αSyn show
progressive loss in OFF transients d. ERGs were recorded from at least 6 animals per genotype (genotype, n1, n10, n30): Rh1-Gal4/+, 17, 13, 14; Rh1 > Tau, 16,
16, 11; Rh1 > Aß, 6, 12, 6; Rh1 > αSyn 9, 10, 14. Subsetted t-tests were performed for post-hoc comparisons of control animals with each experimental
genotype, considering each timepoint independently, and p-values were adjusted using the Bonferroni method. *, p< 0.05; **, p< 0.01; ***p< 0.001
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heads, staining with hematoxylin and eosin. Frontal (Fig. 2)
and tangential (Fig. 3 and Additional file 3: Figure S3)
microtome sections provide complementary views of retinal
structure, allowing detection of any vacuolar changes and
tissue architectural disruption. Tangential sections through
photoreceptors readily permit sensitive detection of photo-
receptor cell loss through counts of rhabdomeres, special-
ized organelles that mediate phototransduction. In contrast
to the rapidly progressive loss of ERG responses, we did
not observe any significant histologic changes in the retina
in Rh1 > Tau flies; numbers and morphology of photore-
ceptors were preserved at all timepoints (Figs. 2 & 3). At
30 days, 92 % of ommatidia in quantified sections from
Rh1 > Tau retinae demonstrated intact ommatidia with 7
visible rhabdomeres at the level examined, which was not
significantly different from Rh1-GAL4/+ controls (Fig. 3).
Thus, when expressed in adult photoreceptors, human
Tau induces progressive neuronal dysfunction, independ-
ent of any detectable neuronal loss or obvious retinal tis-
sue changes.
Aß42
Similar to Tau, Aß expression has previously been demon-
strated to be toxic to Drosophila eye tissue, causing both
disrupted architecture and a rough eye phenotype [10, 21].
These studies have also predominantly relied on the GMR-
GAL4 expression driver, which expresses throughout de-
velopment, including both photoreceptors and supporting,
non-neuronal cells, and produces a rough eye. When ex-
pression of the 42-amino acid Aß peptide (Aß42, referred
to hereafter as Aß) is restricted to adult, differentiated
photoreceptors, using Rh1 > Aß, animals have wildtype
appearing eyes upon visual inspection, without a detectable
roughening (Additional file 2: Figure S2). In contrast to
Rh1 >Tau, ERG recordings from Rh1 >Aß animals do not
show any evidence of rapidly progressive loss in neuronal
function (Fig. 1). In fact, both photoreceptor depolarization
and the associated transient responses were significantly
increased in Rh1 >Aß flies at multiple timepoints. On exam-
ination of retina histology, 1-day old animals showed normal
appearing retinal tissue morphology and architecture (Fig. 2),
and a full complement of photoreceptors was observed in
each ommatidium on tangential sections (Fig. 3). Upon
aging, however, we observed progressive vacuolar changes
affecting the retina, similar to those previously reported in
GMR>Aß flies [21]. In addition, by 30 days we detected
significant reductions in rhabdomere numbers (p < 0.001)
consistent with neuronal loss, such that only 57 % of omma-
tidia in retinae from Rh1 >Aß flies were intact, whereas
similar changes were not seen in Rh1 >Tau (Fig. 3b). Thus,
compared with Tau, Aß induces a markedly distinct pattern
of retinal neurodegeneration, consisting of progressive struc-
tural degeneration and neuronal loss with overall preserved
photoreceptor functioning.
αSyn
Unlike Aß and Tau, αSyn expression in the Drosophila eye
using the GMR-GAL4 driver line does not produce a
rough-eye phenotype. However, modest evidence of toxicity
has been reported on retinal histology [2, 18], including
Fig. 2 Representative frontal sections of the Drosophila retina stained with hematoxylin and eosin demonstrate age-dependent vacuolar change
and tissue loss in Rh1 > Aß and Rh1 > αSyn, but relative preservation Rh1 > Tau. Scale bar: 50 μm
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Fig. 3 (See legend on next page.)
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vacuolar changes, and one study reported ERG changes po-
tentially consistent with disrupted neurotransmission [25].
When previously published UAS:αSyn lines [18] were
expressed using the Rh1 driver, we did not detect any ap-
preciable changes in the ERG depolarization, including with
aging, and only minimal changes were detected on retinal
histology (Additional file 4: Figure S4). Based on the discov-
ery of rare familial forms of synucleinopathy caused by
SNCA locus multiplication [53], αSyn neurotoxicity is dose-
sensitive, and this conclusion has also been supported by
studies of mammalian models [16]. We therefore sought to
develop and test new αSyn transgenic lines, in which codon
usage in the full-length human αSyn cDNA was optimized
for Drosophila, permitting more efficient protein transla-
tion. Indeed, based on western blot analysis, these lines
demonstrate significantly increased αSyn expression levels
(Additional file 4: Figure S4). Consistent with this observa-
tion and compared to αSyn transgenic flies without codon-
optimization, files expressing codon-optimized αSyn under
control of the Rh1-GAL4 driver (hereafter referred to as
Rh1 > αSyn) demonstrated a markedly enhanced toxicity
profile. Using the ERG assay, we find that depolarization
amplitude is initially preserved, but exhibits a modest but
significant, age-dependent decline (versus Rh1 / + controls)
which is apparent at 30 days (8 % reduction, p < 0.05)
(Fig. 1b). ERG off transient potentials show a consistent,
age-dependent loss in Rh1 > αSyn flies (Fig. 1d). On histo-
logical analysis, the retinae of Rh1 > αSyn flies initially
display no obvious morphological defects, but aging leads
to progressive vacuolar changes (Fig. 2) and rhabdomere
loss (Fig. 3), ultimately leading to substantial architectural
disruption and tissue destruction. In 10 day-old animals, we
detected modest but significant reductions in rhabdomere
numbers (p < 0.001) consistent with neuronal loss, such
that 89 % of ommatidia in retinae from Rh1 > αSyn flies
were intact, compared to 97 % in controls (Fig. 3b). By
30 days, the severity of tissue loss and architectural distor-
tion made it impossible to identify preserved ommatidia. In
sum, αSyn expression shows a third characteristic profile of
neurodegeneration in the Drosophila visual system distinct
from either Tau or Aß, causing substantial age-dependent
structural degenerative changes, including cell death, with
comparatively delayed, modest functional deficit based on
ERG depolarization.
Transmission electron microscopy
In order to reveal potential mechanisms underlying the
distinct patterns of toxicity seen using medium through-
put assays, and to understand the discordance between
structural and functional assays, we performed TEM to
examine photoreceptor ultrastructure following expres-
sion of Aß, Tau, or αSyn with the Rh1-GAL4 driver. We
used identical conditions to those described above, and
performed our analysis at 10 days in order to capture the
evolution of age-dependent changes. Based on retinal TEM,
all three toxic proteins induced modest disruptions in
photoreceptor rhabdomeres (Fig. 4), specialized membrane-
rich, electron dense organelles that mediate phototransduc-
tion and thereby generate the ERG depolarization. Com-
pared to Rh1 / + controls, expression of Tau, Aß, or αSyn
caused subtle defects in rhabdomere architecture, including
apparent splitting / “fraying” at the edges, vacuolar changes,
and other irregularities. However, the frequency of these
changes did not appear to correlate well with the extent and
timing of functional deficits as revealed by ERG. Consistent
with findings on retinal histology, rhabdomere disruption
was most frequent in Rh1 > αSyn (~65 %, Fig. 4e) even
though significant changes in ERG depolarization are not
observed at this timepoint. Conversely, despite the profound
reduction in the ERG response characteristic of Rh1 >Tau
flies at 10 days (Fig. 1), the majority of photoreceptors had
preserved rhabdomeres. The resolution afforded by TEM
also allowed us to examine several subcellular systems impli-
cated in neurodegeneration (Fig. 5). While mitochondrial
numbers and morphology were preserved (Fig. 5e), we ob-
served evidence of increased endolysosomal-dependent pro-
cesses (Fig. 5f & g). Specifically, in both Rh1 >Aß and
Rh1 > αSyn, we see increased numbers of multivesicular or
multilamellar bodies, consistent with altered autophagic flux,
whereas in Rh1 >Tau, a preponderance of electron dense
vesicles were seen consistent with the appearance of teloly-
sosomes (also called residual bodies or lipofuscin granules).
Electron-dense material, possibly consistent with granular
(See figure on previous page.)
Fig. 3 a Representative tangential sections of Drosophila retina stained with hematoxylin and eosin show progressive neuronal loss in Rh1 > Aß and
Rh1 > αSyn, but not in Rh1 > Tau. Arrowheads highlight representative ommatidia with < 7 rhabdomeres. Scale bar: 10 μm. See also Additional file 3: Figure
S3 for low-power views. b Photoreceptor loss in tangential sections was quantified based on the percentage of ommatidia with a preserved complement
of 7 rhabdomeres at each timepoint (2-way ANOVA model F-test, p< 0.001). In 30 day-old animals, only 56 % of ommatidia in retinae from Rh1 > Aß flies
had the full complement of 7 rhabdomeres, compared with 92 % in Rh1-GAL4/+ controls (p< 0.001), whereas no significant change was seen in Rh1 >
Tau (92 %). Given the severity of tissue loss at 30 days, it was not possible to identify preserved ommatidia in Rh1 > αSyn flies (ND); however, in 10 day-old
animals, 89 % of ommatidia were intact, compared to 97 % of controls (p< 0.001), consistent with photoreceptor loss. Approximately 100 ommatidia
were examined per 100x field of view for at least 4 animals per genotype. Total number of retinae examined (genotype, n1, n10, n30): Rh1-Gal4/+, 9, 8, 7;
Rh1 > Tau, 7, 7, 10; Rh1 > Aß, 7, 8, 8; Rh1 > αSyn 7, 7, ND. Subsetted t-tests were performed for post-hoc comparisons of control animals with each
experimental genotype, considering each timepoint independently, and p-values were adjusted using the Bonferroni method. At Day 1, SEM= 0 for
Rh1-Gal4/+, Rh1 > Tau, and Rh1 > Aß. ***, p< 0.001
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Fig. 4 (See legend on next page.)
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tau oligomeric aggregates, has previously been observed in
Tau transgenic flies [15].
We next examined the organization and morphology
of photoreceptor synaptic terminals, based on TEM of
the lamina. In control animals (Rh1 / +), TEM reveals a
regular array of “cartridges” in which 6 photoreceptor
synaptic terminals converge and surround the centrally
located dendritic projections from second order neurons
in the Drosophila visual system (Fig. 6a). The cytoplasm
of the photoreceptor terminals appears electron dense
relative to the dendritic processes due to the synaptic
vesicular contents. Expression of Tau or αSyn, but not Aß,
significantly disrupted photoreceptor synaptic terminal
organization and/or morphology. Remarkably, in Rh1 > Tau
animals examined at 10 days, it was no longer possible to
discriminate photoreceptor terminals (Fig. 6a), perhaps due
to a paucity of synaptic vesicles, and the overall architecture
of the lamina was disturbed. By contrast, in Rh1 > αSyn,
overall lamina organization was preserved; however, synap-
tic terminals were significantly enlarged, assuming a bulb-
ous appearance (Fig. 6d and e), and synaptic vesicle density
was found to be decreased (Fig. 6f). Additionally, αSyn
expression appeared to alter synaptic vesicle size, leading to
enlarged and more heterogeneous vesicles (inset, Fig. 6d).
In sum, TEM reveals significant but distinct patterns of
synaptotoxicity following expression of Tau and αSyn in
adult photoreceptors.
Discussion
We report on parallel, systematic assessments of both
structural and functional changes occurring in the Drosoph-
ila retina following expression of human Tau, Aß, and αSyn
under identical conditions. Remarkably, these toxic protein
species are discovered to recapitulate distinct profiles of
neurodegeneration, and the findings highlight a surprising
“uncoupling” between neuronal dysfunction and retinal
destruction/cell loss. Expression of Tau in the adult retina
causes a significant and progressive decline in photorecep-
tor function, based on the ERG, whereas tissue histology
reveals preserved retinal architecture without evidence of
structural degeneration. As discussed further below, Tau-
related neuronal dysfunction has been reported in several
prior Drosophila studies using a variety of complementary
expression conditions and assays [12, 36, 38]. By contrast,
we show that Aß expression has minimal impact on the
ERG but causes progressive retinal vacuolar changes and
associated rhabdomere loss. αSyn expression—based on
new, codon-optimized transgenes—generates a third profile
consisting of rapid, age-dependent histologic destruction of
retinal tissue with comparatively late, and modest change in
photoreceptor field potentials. Finally, ultrastructural
analyses reveal evidence of altered endolysosomal path-
ways following expression of all three proteins, and in
the case of Tau and αSyn, synaptotoxic mechanisms are
strongly implicated. Interestingly, mitochondrial num-
bers and morphology were preserved in all 3 models.
The assays employed in our studies (histology, ERG,
and TEM) are highly complementary, allowing assess-
ments of neurodegenerative changes at the macro-, mi-
cro-, and ultra-structural levels as well as correlation
with retinal neurophysiology. Based on numerous prior
studies, the mechanisms of Aß-, Tau-, and αSyn-
triggered neuronal injury in AD and PD, respectively,
have many features in common, including aggregation,
pathologic propagation [59], and overlapping cytotoxic
profiles (e.g. synaptic changes [4, 56], mitochondrial
dysfunction/oxidative stress [24, 61], and altered pro-
teostasis [34]). Despite these parallels, the distinct de-
generative phenotypes observed following expression of
Tau, Aß, and αSyn expression in the Drosophila eye
suggest these protein species engage at least partially
non-overlapping downstream effector mechanisms.
While we have taken several steps to standardize expres-
sion conditions for Tau, Aß, and αSyn, it is not possible to
exclude the contribution of variation in transgene/protein
expression levels to the observed toxicity profiles. Indeed,
the neurotoxicity of these protein species is highly dose-
dependent in most experimental systems, and human gen-
etic variants that increase Aß and αSyn production are
risk factors for AD and PD, respectively [32, 46]. Based on
quantitative Western blots and ELISA, we estimated the
relative expression of Aß, Tau, and αSyn under our experi-
mental conditions was approximately 1:30:200 (by molar-
ity), respectively (Additional file 1: Figure S1). The
comparatively high αSyn expression levels likely relates to
codon-optimization, which achieves ~20-fold higher ex-
pression compared to previously published transgenic
strains (Additional file 4: Figure S4). While we estimate
that non-codon optimized αSyn has more comparable ex-
pression levels (Aß:Tau:αSyn = 1:30:10), this line demon-
strates minimal toxicity in our assays, perhaps consistent
with more robust neuronal compensatory mechanisms.
(See figure on previous page.)
Fig. 4 Compared to controls (a, Rh1-GAL4 / +), TEM reveals modest ultrastructural defects in rhabdomeres of Rh1 > Tau b, Rh1 > Aß c and
Rh1 > αSyn d flies at 10 days. a Photoreceptor subcellular organelles are labelled, including nucleus (n), rhabdomere (r), mitochondria (m), and
rough endoplasmic reticulum (e). Non-neuronal pigment (p) cells and glia (g) are also noted. e Frequency of photoreceptors with rhabdomere
structural defects was quantified from electron micrographs taken from 3 distinct animals per genotype. Total number photoreceptors quantified
(genotype, n): Rh1-GAL4/+, 614; Rh1 > Aß, 326; Rh1 > Tau, 389; and Rh1 > αSyn, 330. Scale bar: 1 μm. Statistical comparisons were implemented
using a two-tailed student’s t-test. *, p < 0.05; **, p < 0.01; ***, p < 0.001
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Nevertheless, variation in protein expression levels seem
unlikely to account for many of our observations, since
higher expression was in fact a poor predictor of en-
hanced toxicity. For example, despite its relatively
higher expression over Tau, αSyn caused a compara-
tively modest and late disruption in the ERG. Moreover,
despite the significantly lower expression, Aß but not
Tau triggered retinal vacuolar changes and rhabdomere
loss. In the future, it may be informative to repeat our
studies following codon-optimization of Aß42 and Tau
and/or with transgenic strains that use the same gen-
omic insertion site.
One strength of our study is the choice of expression
conditions facilitating comparison of toxicity profiles for
Tau, Aß, and αSyn in adult neurons. We selected the
Rh1-GAL4 expression driver which is activated shortly
prior to eclosion of adult flies within mature, fully differ-
entiated photoreceptors and following patterning and
morphogenesis of the eye [37, 47, 48, 51]. While the
spatiotemporal expression profile of the Rh1 promoter
has been extensively-characterized, we cannot exclude
the possibility of low-level “leaky” transgene expression.
In order to further suppress expression during develop-
ment, including late pupal stages, crosses were estab-
lished at 18 °C and adult animals were shifted to 25 °C
following eclosion. Most prior work using retinal pheno-
types for fly neurodegenerative models have relied on
drivers that express during eye development (GMR-, gl-,
and Sev-GAL4). When Aß [21] or Tau [62] is expressed
in this manner, retinal morphogenesis is disrupted
resulting in a “rough eye”. Importantly, the rough eye
phenotype is readily amenable to enhancer/suppressor
screening, and successful large-scale and unbiased modi-
fier studies have been performed in both Tau [1, 5, 52]
and Aß [9] transgenic flies. However, these developmen-
tal driver lines make it difficult to study the toxicity of
Tau in mature neurons, potentially most relevant for
adult-onset neurodegenerative disorders such as AD and
PD. Notably, the ERG assay used here has also been
deployed successfully for large-scale genetic screens [64].
Another potential advantage of Rh1 is its selectivity for
retinal photoreceptors compared to GMR-GAL4, which
is expressed more broadly within both neuronal and
supporting cells, including glia. Based on studies in the
brain, Tau can also recapitulate toxicity in Drosophila
glia, and neuron-glia interactions can influence overall
levels of degeneration in the nervous system [14]. In
sum, in contrast to much prior work using the Drosoph-
ila eye as a tissue for the study of neurodegeneration,
our findings selectively highlight the impact of Aß, Tau,
or αSyn in post-mitotic neurons.
One unexpected finding is the progressive photorecep-
tor dysfunction in Rh1 > Tau flies that occurs in the
absence of apparent retinal histologic degeneration or
neuronal death. This contrasts not only with the effects of
Aß or αSyn when expressed under identical conditions,
but also with the profound rough eye and associated
retinal histologic changes following developmental expres-
sion of Tau (e.g. GMR-GAL4). Even with the increased
resolution provided by TEM, retinal architecture was sur-
prisingly preserved with significant loss of photoreceptor
depolarization out of proportion to changes in the respon-
sible cellular compartment/structures (i.e. ommatidia/
rhabdomeres). Notably, prior studies of Tau-induced pro-
gressive neurodegeneration in the adult brain [62] have
relied on drivers, such as elav-GAL4, which are also
expressed early in neuronal differentiation. Overall brain
morphology is preserved in these flies; although aberrant
development of selected neuronal structures, such as the
mushroom bodies, have been documented [30]. Poten-
tially related to our observations of “uncoupling” between
neuronal dysfunction and degeneration, Kosmidis et al.
found that certain mutant forms of Tau expressed under
the control of elav-GAL4 disrupt Drosophila olfactory
memory, while apparently preserving mushroom body
morphology [30]. In the context of glia, Colodner and
Feany demonstrated that conditional expression of wild-
type Tau in the adult fly brain is capable of inducing
progressive apoptotic degeneration [14]. Under conditions
in which neuronal expression of Tau is restricted to the
adult brain, Papanikolopoulou and Skoulakis showed that
flies have decreased survival, but neuronal loss and/or
vacuolar changes was not examined [45]. In studies of the
larval peripheral nervous system, Mudher et al. found that
Tau is capable of disrupting axonal transport [38], and
Chee et al. documented Tau-induced synaptic dysfunction
[12], both in the absence of apparent neuronal death. Our
findings of preserved photoreceptors in the retinae of
(See figure on previous page.)
Fig. 5 Compared to controls (a, Rh1-GAL4 / +), TEM reveals evidence of altered autophagy and endo-lysososomal flux in Rh1 > Tau b, Rh1 > Aß c
and Rh1 > αSyn d flies at 10 days, but unchanged mitochondria. Autophagic vacuoles (arrowheads) and electron dense vacuoles (arrows) are indicated.
Quantification e-g of ultrastructural features was based on electron micrographs from 3 distinct animals per genotype. e Number of mitochondria were
quantified per ommatidium. Total number ommatidia counted (genotype, n): Rh1-Gal4/+, 18; Rh1 > Aß, 21; Rh1 > Tau, 20; and Rh1 > αSyn, 18. f Aß and
αSyn induce autophagic vacuole formation in the Drosophila retina. Distinct vacuolar compartments representing autophagic flux were quantified per
photoreceptor area (n / μm2), including autophagosomes, multi-vesicular bodies, multi-lamellar bodies, and lysosomes. g Increased frequency of electron
dense vacuoles following expression of Tau, potentially consistent with the appearance of telolysosomes (also called lipofuscin granules). Total number
photoreceptors quantified (genotype, n): Rh1-GAL4/+, 340; Rh1 > Aß, 269; Rh1 > Tau, 320; and Rh1 > αSyn, 257. Scale bar: 1 μm. All statistical comparisons
were implemented using a two-tailed student’s t-test. *, p< 0.05; **, p< 0.01
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Rh1 > Tau flies appears contradictory to recent findings by
Gorsky et al. [22]; however, our studies differ in the
specific Tau isoform examined, expression driver/condi-
tions, and assays employed. Tau phosphorylation is also
likely an important determinant of the specific profile of
Tau toxicity, based on numerous studies in Drosophila [1,
11, 42, 45, 57] and many other experimental systems [23].
In sum, the alternative outcomes of neuronal dysfunction
versus death following Tau expression may be sensitive to
many factors, including timing, cell-type, protein levels,
isoform, and post-translational modifications.
Early synaptotoxic mechanisms are emerging as important
in the pathogenesis of both AD and PD [44, 49, 56]. Based
on TEM, we observed profound disruption of photoreceptor
terminals in both Rh1 >Tau and Rh1 > αSyn flies; although,
the character of the specific defect was distinct. Tau was as-
sociated with a disorganized lamina architecture, and it was
no longer possible to differentiate photoreceptor terminals.
This is consistent with prior findings of reduced synaptic
markers in Tau flies out of proportion to neuronal cell loss
[35]. One attractive hypothesis is that these changes might
arise from Tau-mediated disruption of axonal transport,
leading to impaired delivery of mitochondria and synaptic
vesicles and resulting in terminal collapse, consistent with
prior observations in a variety of Tauopathy models [17, 26,
38]. Following αSyn expression, TEM revealed an expansion
of the synaptic terminals and enlarged but decreased density
of synaptic vesicles. Notably, similar changes have been doc-
umented in the brains of αSyn transgenic mice [6, 41, 50].
αSyn avidly binds cellular membranes, including synaptic
vesicles and other endomembrane organelles, likely account-
ing for its conserved activity to remodel and disrupt such
systems[4]. Consistent with our TEM findings of disrupted
synaptic ultrastructure, Tau and αSyn were each additionally
associated with progressive decline in the ERG OFF transi-
ent potentials, suggesting impaired neurotransmission [60].
Despite the early and potent synaptotoxicity associated with
Aß in many other systems [44, 56], we did not detect signifi-
cant disruptions in the lamina ultrastructure of Rh1 >Aß
flies. It will be important in the future to examine for pos-
sible emergence of synaptic or other ultrastructural changes
at later timepoints since the Aß-induced histologic findings
are quite sparse at 10 days and could potentially be missed
by TEM due to sampling. Interestingly, despite the age-
dependent photoreceptor loss triggered by Aß, we observed
an initial increase in both the ERG ON/OFF transients along
with the overall increased depolarization amplitude. One
speculative possibility is that these findings reflect cellular
and synaptic functional compensatory mechanisms. While
additional studies will be required to understand these dy-
namic neurophysiologic changes, we note that apparently
paradoxical effects have been previously reported for Aß
species at Drosophila neuromuscular junctions and in mam-
malian neurons [13, 65].
Conclusions
Based on a combination of functional neuroimaging and
clinicopathologic correlation studies, there is increasing
recognition that synaptic and circuit dysfunction contribute
significantly to AD and PD manifestations, and may in fact
precede neuronal death and tissue atrophy [27, 29]. It will
be important to directly address this experimentally in
model systems, and to develop assays that allow mechanistic
studies of functional degenerative changes. In Drosophila,
Aß, Tau, and αSyn transgenic models have been previously
utilized for electrophysiological studies at the larval neuro-
muscular junction [8, 12, 13], but this approach is potentially
limited for the analysis of age-dependent progressive
changes in adult neurons. Nervous system function has also
been probed in fly disease models based on learning and
locomotion in adult animals [19]; however, as discussed
above, the relative contribution of neuronal loss versus
dysfunction to these behaviors remains to be carefully eluci-
dated. In sum, the parallel studies of retinal ERG, histology,
and TEM reported here provide a foundation for future
genetic dissection of mechanisms underlying progressive
synaptic and functional disruption in transgenic models of
AD and PD, and its relation to the cumulative and poten-
tially irreversible burden from tissue destruction and neur-
onal loss.
Additional files
Additional file 1: Figure S1. Quantitation of transgenic expression of
Tau, Aβ, and αSyn. (PDF 130 kb)
Additional file 2: Figure S2. External eye appearance of genotypes
evaluated in this study. (PDF 177 kb)
Additional file 3: Figure S3. Low power histologic sections. (PDF 158 kb)
(See figure on previous page.)
Fig. 6 TEM of the Drosophila lamina (a, Rh1-GAL4 / +) highlights photoreceptor synaptic terminals (dashed black outline) arrayed into cartridges
(white outline). Ultrastructural evidence of synaptotoxic mechanisms is seen in Rh1 > Tau b, and Rh1 > αSyn d flies at 10 days, but not in Rh1 > Aß
c. Insets show higher power views of synaptic terminal contents, revealing apparent enlargement and heterogeneous morphology of synaptic
vesicles in Rh1 > αSyn (compare panel d inset with a and c). e-f Quantification of ultrastructural features based on electromicrographs from 3
distinct animals per genotype. Due to architectural disorganization and altered morphologic appearance, it was not possible to quantify synaptic
terminal features in Rh1 > Tau animals. e αSyn induces an enlargement in synaptic terminal area. Total number synaptic terminals quantified
(genotype, n): Rh1-GAL4/+, 201; Rh1 > Aß, 182; and Rh1 > αSyn, 185. f Decreased synaptic vesicle density following αSyn expression. Synaptic
vesicles were quantified per photoreceptor terminal area (n / μm2). Scale bars: 1 μm (main panel), 0.2 μm (inset). All statistical comparisons were
implemented using a two-tailed student’s t-test. **, p < 0.01; ***p < 0.001
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Additional file 4: Figure S4. Expression and toxicity of non-codon
optimized αSyn. (PDF 141 kb)
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